Company Overview and News

 
CEO Awarded $60 Million to Lead Linn Energy Firm Past Bankruptcy - Bloomberg

2h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Stock Market News For Apr 19, 2018

3h zacks
U.S. stocks closed mixed on Wednesday after gaining over two consecutive winning sessions. However, movements of indexes were modest in either direction. The Dow’s decline was driven by a plunge in the share price of IBM. However, the S&P 500 and Nasdaq finished in the green. Meanwhile, energy stocks gained after a 2.9% surge in oil prices and transportation sector starts off a strong earnings session.
Upvote Downvote

 
Energy Sector: Overbought, But It May Not Matter

12h seekingalpha
Bernie Schaeffer of Schaeffer's Investment Research published this piece on Sunday, April 15. (See below the dotted line.)
Upvote Downvote

1
Exxon faces setback in Iraq as oil and water mix

12h channelnewsasia
Talks between Exxon Mobil and Iraq on a multi-billion-dollar infrastructure contract have reached an impasse, Iraqi officials and two industry sources said, in a potential setback to the oil major's ambitions to expand in the country.
Upvote Downvote

 
Exxon faces setback in Iraq as oil and water mix

12h reuters
LONDON/BASRA, Iraq (Reuters) - Talks between Exxon Mobil (XOM.N) and Iraq on a multi-billion-dollar infrastructure contract have reached an impasse, Iraqi officials and two industry sources said, in a potential setback to the oil major’s ambitions to expand in the country.
Upvote Downvote

 
Liberian President Weah Orders Probe of Exxon 2013 Oil Deal

22h rigzone
(Bloomberg) -- Liberian President George Weah ordered a probe into Exxon Mobil Corp.’s 2013 deal for drilling rights off the West African nation’s coast, his office said.
Upvote Downvote

 
Despite Oil Back Above $68 Per Barrel, 10 Major Oil and Gas Stocks Still Negative So Far in 2018

22h 247wallst
With WTI crude oil putting in another strong day, a gain of more than $2 per barrel has put the price of benchmark crude back above $68.50 per barrel. This marked the highest level going back to when oil prices were falling rapidly in the second half of 2014.
Upvote Downvote

 
Sonatrach says Exxon Mobil considering investment in Algeria

2018-04-18 reuters
ORAN, Algeria (Reuters) - Exxon Mobil is considering investing in Algeria for the first time, a sign the North African country is becoming “more attractive”, the head of Algerian state energy firm Sonatrach said on Wednesday.
Upvote Downvote

 
Colorado communities launch lawsuit against Suncor, Exxon claiming climate change damages

2018-04-18 cbc.ca
Three Colorado communities have filed a lawsuit demanding that Calgary-based Suncor Energy Inc. and U.S. giant Exxon Mobil Corp. "pay their fair share" of costs associated with climate change.
Upvote Downvote

 
Crude Oil Price Jumps on Inventory Drawdowns

2018-04-18 247wallst
The U.S. Energy Information Administration (EIA) released its weekly petroleum status report Wednesday morning showing that U.S. commercial crude inventories decreased by 1.1 million barrels last week, maintaining a total U.S. commercial crude inventory of 427.6 million barrels. The commercial crude inventory remains in the lower half of the average range for this time of year.
Upvote Downvote

1
7 Retirement Stocks for the Coming Correction

2018-04-18 investorplace
I’ve long believed that one of the worst strategies in the market is for investors to “rotate” into so-called defensive stocks. It’s a common piece of advice from experts, particularly in a more volatile market. The strategy sounds cautious, and even wise. In a nervous market, investors should migrate to lower-risk stocks in order to protect their capital.
Upvote Downvote

 
Commodities trader Gunvor joins transparency group EITI

2018-04-18 reuters
* Swiss-based Gunvor Group said on Wednesday that it had joined the Extractive Industries Transparency Initiative (EITI), an international effort to fight corruption in managing revenues from oil, gas and mineral extraction
Upvote Downvote

 
Liberian President Weah Orders Probe of Exxon's 2013 Oil Deal - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Oil & Gas Stock Roundup: CVX's Gorgon Expansion, MDR & NOV's Operational Updates & More

2018-04-17 zacks
On the news front, U.S. supermajor Chevron Corp. (CVX - Free Report) gave its go-ahead to the $5.1 billion second stage of its massive Gorgon LNG project in Western Australia, while oilfield service providers McDermott International, Inc. (MDR - Free Report) and National Oilwell Varco, Inc. (NOV - Free Report) provided first-quarter operational updates.
Upvote Downvote

 
Latest legal fight accusing oil companies of climate change launched in Colorado

2018-04-17 reuters
NEW YORK, April 17 (Thomson Reuters Foundation) - Three Colorado communities filed a lawsuit against oil companies on Tuesday, launching the latest legal battle seeking damages for what they claim are the costs of adapting to climate change.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 30231G102